.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Cerilliant
Queensland Health
Fish and Richardson
Mallinckrodt
Cipla
Moodys
Covington
Medtronic

Generated: November 21, 2017

DrugPatentWatch Database Preview

Medicis Company Profile

« Back to Dashboard

What is the competitive landscape for MEDICIS, and when can generic versions of MEDICIS drugs launch?

MEDICIS has twenty approved drugs.

There are twenty-six US patents protecting MEDICIS drugs.

There are one hundred and seventy-eight patent family members on MEDICIS drugs in forty-nine countries and forty-two supplementary protection certificates in eleven countries.

Summary for Medicis

International Patents:178
US Patents:26
Tradenames:19
Ingredients:17
NDAs:20
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis
SOLODYN
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL050808-007Aug 27, 2010ABRXYesNo► Subscribe► Subscribe ► Subscribe
Medicis
SOLODYN
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL050808-003May 8, 2006DISCNYesNo► Subscribe► Subscribe ► Subscribe
Medicis
SOLODYN
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL050808-002May 8, 2006DISCNYesNo► Subscribe► Subscribe ► Subscribe
Medicis
NORFLEX
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL012157-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Medicis
VANOS
fluocinonide
CREAM;TOPICAL021758-001Feb 11, 2005ABRXYesYes► Subscribe► Subscribe ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Medicis
SOLODYN
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL050808-006Aug 27, 2010ABRXYesNo► Subscribe► Subscribe ► Subscribe
Medicis
ALDARA
imiquimod
CREAM;TOPICAL020723-001Feb 27, 1997ABRXYesYes► Subscribe► SubscribeY► Subscribe
Medicis
SOLODYN
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL050808-005Jul 23, 2009RXYesYes► Subscribe► Subscribe ► Subscribe
Medicis
CALCIUM DISODIUM VERSENATE
edetate calcium disodium
TABLET;ORAL008922-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Medicis

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis
ZIANA
clindamycin phosphate; tretinoin
GEL;TOPICAL050802-001Nov 7, 2006► Subscribe► Subscribe
Medicis
METROGEL-VAGINAL
metronidazole
GEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
Medicis
METROGEL-VAGINAL
metronidazole
GEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
Medicis
ALDARA
imiquimod
CREAM;TOPICAL020723-001Feb 27, 1997► Subscribe► Subscribe
Medicis
ALDARA
imiquimod
CREAM;TOPICAL020723-001Feb 27, 1997► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003► Subscribe► Subscribe
Medicis
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION020014-001Nov 30, 1992► Subscribe► Subscribe
Medicis
METROGEL-VAGINAL
metronidazole
GEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
Medicis
ZIANA
clindamycin phosphate; tretinoin
GEL;TOPICAL050802-001Nov 7, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MEDICIS drugs

Drugname Dosage Strength Tradename Submissiondate
imiquimod
Cream2.5%
ZYCLARA
6/17/2014
imiquimod
Cream3.75%
ZYCLARA
8/8/2012
minocycline hydrochloride
Extended-release Tablet105 rng
SOLODYN
12/28/2010
clindamycin phosphate and tretinoin
Gel1.2%/0.025%
ZIANA
12/17/2010
minocycline hydrochloride
Extended-release Tablet55 mg and 80 mg
SOLODYN
12/2/2010
minocycline hydrochloride
Extended-release Tablets65 mg and 115 mg
SOLODYN
11/19/2009
fluocinonide
Cream0.10%
VANOS
1/31/2008
imiquimod
Cream5%
ALDARA
10/17/2006
ciclopirox
Gel0.77%
LOPROX
5/10/2006
metronidazole
Vaginal Gel0.75%
METROGEL-VAGINAL
9/2/2004

Non-Orange Book Patents for Medicis

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,271,973Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy► Subscribe
6,517,847 Topical gel delivery system► Subscribe
9,370,5092.times.2.times.2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod► Subscribe
7,771,733Compositions and methods for enhancing corticosteroid delivery► Subscribe
9,085,554Method of evaluating pharmaceutical preparation containing luliconazole and index substance► Subscribe
7,217,422Compositions and methods for enhancing corticosteroid delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Medicis Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014041708► Subscribe
United Kingdom2317615► Subscribe
Germany19639818► Subscribe
European Patent Office2895479► Subscribe
Australia2001279002► Subscribe
Canada2649893► Subscribe
Germany59705697► Subscribe
Indonesia21874► Subscribe
Brazil9711575► Subscribe
Poland188033► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Medicis Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
C0022France► SubscribePRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
90018-6Sweden► SubscribePRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
90020-1Sweden► SubscribePRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
C/GB97/078United Kingdom► SubscribePRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
C0021France► SubscribePRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
C0052France► SubscribePRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
C0108Belgium► SubscribePRODUCT NAME: MANGAFODIPIR TRISODIUM (ANHYDROUS) CORRESP. MANGAFODIPIR; REGISTRATION NO/DATE: EU/1/97/040/001 19970522
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C0055France► SubscribePRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Argus Health
Federal Trade Commission
Cantor Fitzgerald
Farmers Insurance
UBS
Healthtrust
Novartis
Cerilliant
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot